Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD: A Randomized Trial.
CONCLUSIONS: As compared with ferrous sulfate, treatment with ferric citrate for 12 weeks resulted in a greater mean increase in TSAT and ferritin concentrations in individuals with moderate to severe CKD and iron deficiency.
CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With Moderate to Severe Chronic Kidney Disease (CKD) With Iron Deficiency, NCT02888171.
PMID: 32694162 [PubMed - as supplied by publisher]
Source: Clinical Journal of the American Society of Nephrology : CJASN - Category: Urology & Nephrology Authors: Womack R, Berru F, Panwar B, GutiƩrrez OM Tags: Clin J Am Soc Nephrol Source Type: research
More News: Anemia | Chronic Kidney Disease | Clinical Trials | Dialysis | Iron | Study | Urology & Nephrology